ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study.
Ontology highlight
ABSTRACT: Electroencephalography (EEG)-neurofeedback has been shown to offer therapeutic benefits to patients with attention-deficit/hyperactivity disorder (ADHD) in several, mostly uncontrolled studies. This pilot study is designed to test the feasibility and safety of using a double-blind placebo feedback-controlled design and to explore the initial efficacy of individualized EEG-neurofeedback training in children with ADHD. Fourteen children (8-15 years) with ADHD defined according to the DSM-IV-TR criteria were randomly allocated to 30 sessions of EEG-neurofeedback (n = 8) or placebo feedback (n = 6). Safety measures (adverse events and sleep problems), ADHD symptoms and global improvement were monitored. With respect to feasibility, all children completed the study and attended all study visits
SUBMITTER: Lansbergen MM
PROVIDER: S-EPMC3051071 | biostudies-literature | 2011 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA